Immediate Impact
1 by Nobel laureates 4 from Science/Nature 54 standout
Citing Papers
mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
Mechanisms of long COVID and the path toward therapeutics
2024 Standout
Works of Benjamin D. McElvany being referenced
Kinetics and isotype assessment of antibodies targeting the spike protein receptor‐binding domain of severe acute respiratory syndrome‐coronavirus‐2 in COVID‐19 patients as a function of age, biological sex and disease severity
2020
In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Benjamin D. McElvany | 191 | 174 | 46 | 68 | 12 | 367 | |
| Abdoulaye Barry | 98 | 133 | 70 | 89 | 22 | 398 | |
| Faisal Wahid | 59 | 139 | 73 | 180 | 10 | 403 | |
| Anne‐Claire Bréhin | 191 | 211 | 100 | 60 | 14 | 376 | |
| Sébastien Bertin-Maghit | 132 | 120 | 62 | 165 | 10 | 381 | |
| Robert A. Fiske | 213 | 74 | 28 | 58 | 19 | 408 | |
| Lindsey E. Cook | 117 | 136 | 44 | 120 | 6 | 309 | |
| Hannah Bernin | 152 | 72 | 28 | 96 | 10 | 344 | |
| Annette Pohl‐Koppe | 118 | 45 | 35 | 105 | 15 | 352 | |
| Annegret Bitzer | 125 | 133 | 126 | 78 | 8 | 321 | |
| Felicity E. Lumb | 110 | 53 | 134 | 89 | 14 | 381 |
All Works
Login with ORCID to disown or claim papers
Loading papers...